Michael L. Tidwell

Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial

Judith E. Karp, Jeffrey E. Lancet, Scott H. Kaufmann et al. · Blood · 2001 · 445 citations · Full text

Medicine, Oncology, Pharmacology +9

Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias

Ivana Gojo, Anchalee Jiemjit, Jane B. Trepel et al. · Blood · 2006 · 283 citations · Full text

Medicine, Oncology, Pharmacology +17

Timed sequential therapy of acute leukemia with flavopiridol: in vitro model for a phase I clinical trial.

Judith E. Karp, Douglas D. Ross, Weidong Yang et al. · PubMed · 2003 · 82 citations

Medicine, Oncology, Pharmacology +17

Phase I and Pharmacokinetic Study of Flavopiridol followed by 1-β-<scp>d</scp>-Arabinofuranosylcytosine and Mitoxantrone in Relapsed and Refractory Adult Acute Leukemias

Judith E. Karp, Antonino Passaniti, Ivana Gojo et al. · Clinical Cancer Research · 2005 · 78 citations

Medicine, Oncology, Pharmacology +16

Phase I and pharmacokinetic study of Triapine®, a potent ribonucleotide reductase inhibitor, in adults with advanced hematologic malignancies

Ivana Gojo, Michael L. Tidwell, Jacqueline M. Greer et al. · Leukemia Research · 2007 · 74 citations

Medicine, Pharmacokinetics, Pharmacology +11